---
schema_version: "secwatch.filing_event.v1"
accession: "0001558370-23-005339"
form_type: "8-K"
ticker: "TECH"
cik: "0000842023"
company_name: "BIO-TECHNE Corp"
filed_at: "2023-04-03T23:59:59+00:00"
generated_at: "2026-06-17T07:27:35.881000+00:00"
event_type: "m_and_a"
sentiment: "positive"
materiality_score: 0.8
calibrated_materiality_score: 0.8
confidence: "high"
source: SEC EDGAR
---

# Bio-Techne completes $257M investment for 20% stake in Wilson Wolf; future buyout potential $1B

## Summary
- $257M investment gives Bio-Techne 20% ownership of Wilson Wolf Manufacturing.
- Investment triggered by Wilson Wolf achieving $55M trailing twelve-month EBITDA.
- Bio-Techne has right to acquire remaining 80% for $1B if Wilson Wolf reaches $226M revenue or $136M EBITDA.
- If milestone not met by Dec 31, 2027, acquisition price ~4.4x trailing twelve-month revenue.
- Wilson Wolf develops G-Rex cell production technology for cell and gene therapy; used by over 800 CGT market participants.

## SEC filing metadata
- accession: 0001558370-23-005339
- form_type: 8-K
- ticker: TECH
- cik: 0000842023
- company_name: BIO-TECHNE Corp
- filed_at: 2023-04-03T23:59:59+00:00
- event_type: m_and_a
- sentiment: positive
- materiality_score: 0.8
- calibrated_materiality_score: 0.8
- confidence: high
- sec_items: 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/842023/000155837023005339/0001558370-23-005339-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/842023/000155837023005339/tmb-20230331x8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001558370-23-005339
- JSON: https://secwatch.observer/filing/0001558370-23-005339.json
- Plain text: https://secwatch.observer/filing/0001558370-23-005339.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.